Physician Resources: Beta-Catenin & Hepatocellular Cancer: From bench to Bedside

In this CME, Satdarshan (Paul) S. Monga, MD discusses how to explain the molecular subclasses of hepatocellular cancers (HCCs) in particular the subclass driven by CTNNB1 mutations leading to Wnt-beta-catenin activation (around 35-40% of all HCCs), describe metabolic addiction of CTNNB1-mutated HCC that is a therapeutic vulnerability and being investigated in a clinical trial, and implement the management of CTNNB1-mutated HCC by direct targeting of beta-catenin using siRNA and lipid nanoparticle impacting tumor cell survival and immune microenvironment as a precision medicine clinical trial.

Target Audience

 

    Learning Objectives

    Upon completion of this activity, participants should be able to:

    • Explain the molecular subclasses of hepatocellular cancers (HCCs) in particular the subclass driven by CTNNB1 mutations leading to Wnt-beta-catenin activation (around 35-40% of all HCCs)
    • Describe metabolic addiction of CTNNB1-mutated HCC that is a therapeutic vulnerability and being investigated in a clinical trial
    • Implement the management of CTNNB1-mutated HCC by direct targeting of beta-catenin using siRNA and lipid nanoparticle impacting tumor cell survival and immune microenvironment as a precision medicine clinical trial

    Course summary

    Available credit: 
    • 1.00 AMA PRA Category 1 Credit™
      The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
    • 1.00 Attendance
    Course opens: 
    10/26/2026
    Course expires: 
    10/26/2029

    Satdarshan (Paul) Singh Monga, MD

    SVC Chair in Pathobiology and Therapeutics Chair and Professor of Pharmacology Professor of Medicine Director, Organ Pathobiology and Therapeutics Institute Director, Pittsburgh Liver Research Center Associate Dean of Research, School 

    Available Credit

    • 1.00 AMA PRA Category 1 Credit™
      The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
    • 1.00 Attendance
    Please login or register to take this course.